CAJ | 학술논문

脑卒中是一种具有高发病率、高病死率、高致残率特点的疾病，全球脑卒中防治形势严峻，抗血小板聚集治疗能够有效预防缺血性脑卒中的发生及复发，目前已有多项关于抗血小板药物治疗效果的研究，本文针对抗血小板聚集药物的作用机制及药物特征，以及新型抗血小板药物进行综述，旨在提高临床医师对各种抗血小板聚集药物的认识，在缺血性脑卒中治疗中谨慎选择抗血小板聚集药物。
뇌졸중시일충구유고발병솔、고병사솔、고치잔솔특점적질병，전구뇌졸중방치형세엄준，항혈소판취집치료능구유효예방결혈성뇌졸중적발생급복발，목전이유다항관우항혈소판약물치료효과적연구，본문침대항혈소판취집약물적작용궤제급약물특정，이급신형항혈소판약물진행종술，지재제고림상의사대각충항혈소판취집약물적인식，재결혈성뇌졸중치료중근신선택항혈소판취집약물。
Stroke is a disease that featured high morbidity , high mortality and high disability rate .The treatment of stroke faces with a grim situation world wide .Anti-platelet aggregation therapy is effective in the prevention of the occurrence and relapse of ischemic stroke .At present, there are already multiple researches about the diversity of anti -platelet drugs.This study made a review of mechanism and characteristics of anti -platelet aggregation drugs and new -type anti-platelet drugs , in order to improve clinical doctors′knowledge about various anti -platelet aggregation drugs and help them make wise choices of anti-platelet aggregation drugs in the treatment of ischemic stroke .